Ignite Creation Date:
2025-12-24 @ 3:34 PM
Ignite Modification Date:
2026-01-05 @ 5:31 PM
Study NCT ID:
NCT06956092
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-02
First Post:
2025-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
Sponsor:
Zhengzhou University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2025-IIT-0013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None